About
Remedium Bio develops gene therapy treatments using its proprietary Prometheus™ adjustable gene therapy platform, enabling subcutaneous delivery of adjustable dose gene therapies for diseases including endocrinology, neurology, and rheumatology.
Explore Remedium Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.